157 related articles for article (PubMed ID: 16558087)
1. Immunotherapy of Cancer with Nonliving BCG and Fractions Derived from Mycobacteria: Role of Cord Factor (Trehalose-6, 6'-Dimycolate) in Tumor Regression.
Bekierkunst A; Wang L; Toubiana R; Lederer E
Infect Immun; 1974 Nov; 10(5):1044-50. PubMed ID: 16558087
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy of cancer with nonliving mycobacteria and cord factor (trehalose-6,6'-dimycolate) in aqueous medium.
Bekierkunst A
J Natl Cancer Inst; 1976 Oct; 57(4):963-4. PubMed ID: 187785
[TBL] [Abstract][Full Text] [Related]
3. Influence of type of oil and surfactant concentration on the efficacy of emulsified Mycobacterium bovis BCG cell walls to induce tumor regression in guinea pigs.
Yarkoni E; Rapp HJ
Infect Immun; 1980 Jun; 28(3):881-6. PubMed ID: 6995325
[TBL] [Abstract][Full Text] [Related]
4. Tumor regression after intralesional injection of mycobacterial components emulsified in 2,6,10,15,19,23-hexamethyl-2,6,10,14,18,22-tetracosahexaene (squalene), 2,6,10,15,19,23-hexamethyltetracosane (squalane), peanut oil, or mineral oil.
Yarkoni E; Rapp HJ
Cancer Res; 1979 May; 39(5):1518-20. PubMed ID: 427795
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy of cancer: tumor suppression and regression by cell walls of Mycobacterium phlei attached to oil droplets.
Gray GR; Ribi E; Granger D; Parker R; Azuma I; Yamamoto K
J Natl Cancer Inst; 1975 Sep; 55(3):727-30. PubMed ID: 1159851
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy of guinea pig line 10 hepatoma with nonliving BCG cells in aqueous medium.
Bekierkunst A; Goren MB
Infect Immun; 1979 Jun; 24(3):817-20. PubMed ID: 381203
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy and vaccination against cancer with non-living BCG and cord factor (trehalose-6,6'-dimycolate).
Bekierkunst A
Int J Cancer; 1975 Sep; 16(3):442-7. PubMed ID: 170221
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy of experimental cancer with a mixture of synthetic muramyl dipeptide and trehalose dimycolate.
Yarkoni E; Lederer E; Rapp HJ
Infect Immun; 1981 Apr; 32(1):273-6. PubMed ID: 7216489
[TBL] [Abstract][Full Text] [Related]
9. Intratumor chemoimmunotherapy with mitomycin C and components from mycobacteria in regression of line 10 tumors in guinea pigs.
McLaughlin CA; Cantrell JL; Ribi E; Goldberg EP
Cancer Res; 1978 May; 38(5):1311-6. PubMed ID: 205361
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy of guinea pigs with a transplanted hepatoma: comparison of intralesionally administered killed BCG cells and BCG cell walls.
Yarkoni E; Rapp HJ
Infect Immun; 1979 Sep; 25(3):1087-9. PubMed ID: 387592
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy of an ascitic rat hepatoma with cord factor (trehalose-6, 6'-dimycolate) and synthetic analogues.
Pimm MV; Baldwin RW; Polonsky J; Lederer E
Int J Cancer; 1979 Dec; 24(6):780-5. PubMed ID: 544531
[TBL] [Abstract][Full Text] [Related]
12. Effective nonliving vaccine against experimental tuberculosis in mice.
Ribi E; Larson C; Wicht W; List R; Goode G
J Bacteriol; 1966 Mar; 91(3):975-83. PubMed ID: 4956339
[TBL] [Abstract][Full Text] [Related]
13. Intratumoral BCG therapy of transplanted head and neck tumors in strain 2 guinea pigs.
Bier J; Bier H; Kleinschuster S; Rapp H
Head Neck Surg; 1982; 4(6):457-67. PubMed ID: 7118547
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy with nonviable microbial components.
Ribi E; Milner KC; Granger DL; Kelly MT; Yamamoto K; Brehmer W; Parker R; Smith RF; Strain SM
Ann N Y Acad Sci; 1976; 277(00):228-38. PubMed ID: 187099
[TBL] [Abstract][Full Text] [Related]
15. Influence of oil concentration on the efficacy of tumor regression by emulsified components of mycobacteria.
Yarkoni E; Rapp HJ
Cancer Res; 1979 Feb; 39(2 Pt 1):535-7. PubMed ID: 761228
[TBL] [Abstract][Full Text] [Related]
16. Tumor regression after intralesional injection of emulsified trehalose-6,6'-dimycolate (cord factor): efficacy increases with oil concentration.
Yarkoni E; Meltzer MS; Rapp HJ
Int J Cancer; 1977 Jun; 19(6):818-21. PubMed ID: 326683
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy of guinea pigs with dermal and visceral tumor implants: comparison of living and nonliving BCG.
Yarkoni E; Peters L; Rapp HJ; Hanna MG; Hunter JT
Infect Immun; 1979 May; 24(2):565-66. PubMed ID: 378859
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous granulomatous response to BCG cell walls with reference to cancer immunotherapy.
Granger DL; Brehmer W; Brehmer W; Yamamoto K; Ribi E
Infect Immun; 1976 Feb; 13(2):543-53. PubMed ID: 770333
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of nonspecific immunity to bacterial infection by cord factor (6,6'-trehalose dimycolate).
Parant M; Parant F; Chedid L; Drapier JC; Petit JF; Wietzerbin J; Lederer
J Infect Dis; 1977 May; 135(5):771-7. PubMed ID: 404368
[TBL] [Abstract][Full Text] [Related]
20. Eradication by active specific immunotherapy of established tumor transplants and microscopic lymph node metastases.
Yarkoni E; Ashley MP; Zbar B; Sugimoto T; Rapp HJ
Cancer Res; 1982 Jul; 42(7):2544-6. PubMed ID: 7083146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
